QuidelOrtho
QDEL · NASDAQ
Bulios Fair Price
$6.76
37.8% downside
Current Price
$10.86
According to Bulios Fair Price, QDEL is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
QuidelOrtho Corporation is a global biotechnology company specializing in diagnostics and rapid testing. Formed through the merger of Quidel Corporation and Ortho Clinical Diagnostics, it has become a leader in diagnostic tests, focusing on infectious disease detection, immunoassays, and tests for chronic conditions. QuidelOrtho develops innovative diagnostic tools that accelerate diagnosis and improve healthcare, with products aimed at hospitals, laboratories, and home testing.
Sector
Healthcare
Industry
Medical - Specialties
CEO
Brian J. Blaser
Employees
6,500
Headquarters
San Diego
Upcoming events
Earnings
Upcoming earnings report